Medicine at the Crossroads: Visions, Approaches, and Emerging Frontiers

As we step into 2026, Medicine Advances extends warm greetings to our global community of readers and contributors, celebrating a year of significant growth and academic achievement. The past year, 2025, marked notable expansion in the journal's reach and impact, highlighted by pivotal developments that have shaped our trajectory. Our inclusion in Emerging Sources Citation Index (ESCI) and Scopus stands out as a key milestone, enhancing the visibility and reach of the rigorous, translational, and interdisciplinary research we publish, and affirming the journal's continued maturation. Equally important was the publication of our inaugural special issue AI-Based Quantitative Medical Imaging in Cancer Evolution. This collection wove together expertise from imaging science, artificial intelligence, oncology, biomedical engineering, and clinical practice—demonstrating how data-driven approaches are redefining diagnostics, deepening insights into disease dynamics, and enabling more personalized clinical decisions. Alongside these advances, Medicine Advances has deepened engagement with the global research community—especially early-career researchers—by fostering dialog, collaboration, and mentorship, thereby contributing to a more inclusive and sustainable scholarly ecosystem. Looking ahead, medicine is entering a transformative era, guided by evolving frameworks that reshape our understanding of health and disease. Conditions such as chronic kidney disease exemplify the “one disease, multiple interventions” paradigm, where management extends beyond organ function to encompass blood pressure, glucose metabolism, and systemic health. This integrated view underscores the interconnected pathways of disease progression and informs both research and clinical strategies that embrace complexity and personalization. Methodological innovation is accelerating in tandem. Multi-omics integration allows simultaneous profiling of genomic, transcriptomic, and proteomic layers, unveiling cross-scale biological interactions, while virtual cell modeling enables computational simulation of cellular behavior and disease progression—sharpening the precision of experimental design and clinical prediction. Together, these approaches form a robust scaffold for deciphering complex pathophysiology and designing targeted interventions. Concurrently, advanced technologies are amplifying the power of these methods. Large-scale foundation models can process massive, multimodal datasets to uncover otherwise hidden patterns, and multi-agent systems simulate dynamic interactions among biological or clinical variables—offering sophisticated tools for individualized intervention and clinical decision-making. The convergence of these technologies strengthens the bridge between discovery and practice, paving the way toward a more predictive, mechanism-aware, and translational medical future. Within this dynamic landscape, Medicine Advances remains dedicated to supporting research that integrates conceptual depth, methodological rigor, and technological innovation. We seek to champion studies that advance from insight to explanation, from observation to mechanism, and from isolated findings toward a cohesive vision of tomorrow's medicine—promoting a more intelligent, integrative, and globally responsive medical science. On behalf of the editorial team, I extend our deepest gratitude to all authors, reviewers, editorial board members, and young scholars. Your wisdom, trust, and dedicated efforts were instrumental to the journal's progress in 2025 and have laid a strong foundation for an ambitious 2026. Let us now move forward together, advancing medical science toward a future that is more precise, intelligent, and sustainable. Xueqing Yu: conceptualization, writing–original draft, writing–review and editing. The author has nothing to report. The author has nothing to report. The author has nothing to report. The author has nothing to report. Xueqing Yu is the Editor-in-Chief for Medicine Advances and was not involved in the editorial review or the decision to publish this article. Data sharing is not applicable to this article as no datasets were generated or analyzed.